Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IELSG 26: Rituximab and Chemotherapy in PMBCL
NCT00689845Phase 2Unknown
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Start
- Jun 2007
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in primary mediastinal B-cell lymphoma (PMBCL), sponsored by University Hospital Southampton NHS Foundation Trust. Status: unknown.
02
Drugs
rituximab
03
Conditions
primary mediastinal B-cell lymphoma (PMBCL)
Beyond the preview
Go deeper on NCT00689845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00689845.